382 related articles for article (PubMed ID: 17320630)
1. Surgical management of pediatric Cushing's disease.
Das NK; Lyngdoh BT; Bhakri BK; Behari S; Bhatia V; Jain VK; Banerji D
Surg Neurol; 2007 Mar; 67(3):251-7; discussion 257. PubMed ID: 17320630
[TBL] [Abstract][Full Text] [Related]
2. Outcomes after repeat transsphenoidal surgery for recurrent Cushing's disease.
Patil CG; Veeravagu A; Prevedello DM; Katznelson L; Vance ML; Laws ER
Neurosurgery; 2008 Aug; 63(2):266-70; discussion 270-1. PubMed ID: 18797356
[TBL] [Abstract][Full Text] [Related]
3. Surgical treatment of recurrent Cushing's disease.
Hofmann BM; Hlavac M; Kreutzer J; Grabenbauer G; Fahlbusch R
Neurosurgery; 2006 Jun; 58(6):1108-18; discussion 1108-18. PubMed ID: 16723890
[TBL] [Abstract][Full Text] [Related]
4. Single-center experience with pediatric Cushing's disease.
Kanter AS; Diallo AO; Jane JA; Sheehan JP; Asthagiri AR; Oskouian RJ; Okonkwo DO; Sansur CA; Vance ML; Rogol AD; Laws ER
J Neurosurg; 2005 Nov; 103(5 Suppl):413-20. PubMed ID: 16302612
[TBL] [Abstract][Full Text] [Related]
5. Early post-operative ACTH and cortisol as predictors of remission in Cushing's disease.
Acebes JJ; Martino J; Masuet C; Montanya E; Soler J
Acta Neurochir (Wien); 2007; 149(5):471-7; discussion 477-9. PubMed ID: 17406780
[TBL] [Abstract][Full Text] [Related]
6. Repeated transsphenoidal pituitary surgery (TS) via the endoscopic technique: a good therapeutic option for recurrent or persistent Cushing's disease (CD).
Wagenmakers MA; Netea-Maier RT; van Lindert EJ; Timmers HJ; Grotenhuis JA; Hermus AR
Clin Endocrinol (Oxf); 2009 Feb; 70(2):274-80. PubMed ID: 18616702
[TBL] [Abstract][Full Text] [Related]
7. Transsphenoidal surgery for Cushing's disease: a review of success rates, remission predictors, management of failed surgery, and Nelson's Syndrome.
Kelly DF
Neurosurg Focus; 2007; 23(3):E5. PubMed ID: 17961026
[TBL] [Abstract][Full Text] [Related]
8. Current state of the art in the diagnosis and surgical treatment of Cushing disease: early experience with a purely endoscopic endonasal technique.
Dehdashti AR; Gentili F
Neurosurg Focus; 2007; 23(3):E9. PubMed ID: 17961027
[TBL] [Abstract][Full Text] [Related]
9. Acquired prolactin deficiency (APD) after treatment for Cushing's disease is a reliable marker of irreversible severe GHD but does not reflect disease status.
Mukherjee A; Murray RD; Teasdale GM; Shalet SM
Clin Endocrinol (Oxf); 2004 Apr; 60(4):476-83. PubMed ID: 15049963
[TBL] [Abstract][Full Text] [Related]
10. The use of postoperative ACTH levels as a marker for successful transsphenoidal microsurgery in Cushing's disease.
Flitsch J; Knappe UJ; Lüdecke DK
Zentralbl Neurochir; 2003; 64(1):6-11. PubMed ID: 12582940
[TBL] [Abstract][Full Text] [Related]
11. Outcome of transsphenoidal surgery for Cushing's disease: a high remission rate in ACTH-secreting macroadenomas.
Fomekong E; Maiter D; Grandin C; Raftopoulos C
Clin Neurol Neurosurg; 2009 Jun; 111(5):442-9. PubMed ID: 19200645
[TBL] [Abstract][Full Text] [Related]
12. Management of Cushing's disease using cavernous sinus sampling: effectiveness in tumor lateralization.
Gazioglu N; Ulu MO; Ozlen F; Albayram S; Islak C; Kocer N; Oz B; Tanriover N; Yetkin DO; Gundogdu S; Acbay O; Kadioglu P
Clin Neurol Neurosurg; 2008 Apr; 110(4):333-8. PubMed ID: 18314256
[TBL] [Abstract][Full Text] [Related]
13. Long-term remission rates after pituitary surgery for Cushing's disease: the need for long-term surveillance.
Atkinson AB; Kennedy A; Wiggam MI; McCance DR; Sheridan B
Clin Endocrinol (Oxf); 2005 Nov; 63(5):549-59. PubMed ID: 16268808
[TBL] [Abstract][Full Text] [Related]
14. FSH-producing macroadenoma associated in a patient with Cushing's disease.
Oyama K; Yamada S; Hukuhara N; Hiramatsu R; Taguchi M; Yazawa M; Matsuda A; Ohmura E; Imai Y
Neuro Endocrinol Lett; 2006 Dec; 27(6):733-6. PubMed ID: 17187002
[TBL] [Abstract][Full Text] [Related]
15. Pituitary surgery for Cushing's disease.
Buchfelder M; Schlaffer S
Neuroendocrinology; 2010; 92 Suppl 1():102-6. PubMed ID: 20829628
[TBL] [Abstract][Full Text] [Related]
16. Factors influencing cure by transsphenoidal selective adenomectomy in paediatric Cushing's disease.
Storr HL; Afshar F; Matson M; Sabin I; Davies KM; Evanson J; Plowman PN; Besser GM; Monson JP; Grossman AB; Savage MO
Eur J Endocrinol; 2005 Jun; 152(6):825-33. PubMed ID: 15941921
[TBL] [Abstract][Full Text] [Related]
17. Intra- and postoperative plasma ACTH concentrations in patients with Cushing's disease cured by transsphenoidal pituitary surgery.
Czirják S; Bezzegh A; Gál A; Rácz K
Acta Neurochir (Wien); 2002 Oct; 144(10):971-7; discussion 977. PubMed ID: 12382124
[TBL] [Abstract][Full Text] [Related]
18. Biochemical predictors of outcome of pituitary surgery for Cushing's disease.
Alwani RA; de Herder WW; van Aken MO; van den Berge JH; Delwel EJ; Dallenga AH; De Jong FH; Lamberts SW; van der Lely AJ; Feelders RA
Neuroendocrinology; 2010; 91(2):169-78. PubMed ID: 19907141
[TBL] [Abstract][Full Text] [Related]
19. Dynamics of postoperative serum cortisol after transsphenoidal surgery for Cushing's disease: implications for immediate reoperation and remission.
Mayberg M; Reintjes S; Patel A; Moloney K; Mercado J; Carlson A; Scanlan J; Broyles F
J Neurosurg; 2018 Nov; 129(5):1268-1277. PubMed ID: 29271716
[TBL] [Abstract][Full Text] [Related]
20. Negative surgical exploration in patients with Cushing's disease: benefit of two-thirds gland resection on remission rate and a review of the literature.
Carr SB; Kleinschmidt-DeMasters BK; Kerr JM; Kiseljak-Vassiliades K; Wierman ME; Lillehei KO
J Neurosurg; 2018 Nov; 129(5):1260-1267. PubMed ID: 29219752
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
